HCl-binding compositions for and methods of treating acid-base disorders
US11406661B2 · kind B2 · utility
3Cited by
47References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2017 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Jan 1, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08F226/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.